Therapeutic effects of cefozopran on polymicrobial infections associated with Enterococcus faecalis in a Rat pyometra model

Chemotherapy. 1998 Mar-Apr;44(2):103-7. doi: 10.1159/000007100.

Abstract

Enterococcus faecalis plays an important role as a pathogen in polymicrobial infections. We evaluated the efficacy of cefozopran (CZOP) using polymicrobial pyometra rats. Rats were infected with a mixed intrauterine inoculation of E. faecalis plus either Bacteroides fragilis or Prevotella bivia (minimal inhibitory concentration of CZOP; E. faecalis: 6.25 micrograms/ml, B. fragilis: 12.5 micrograms/ml, P. bivia: 12.5 micrograms/ml). Immediately after inoculating 10(5) CFU of each organism/rat, CZOP (either 40 mg/kg, i.v., q.i.d., for 5 days or 80 mg/kg, i.v., b.i.d., for 5 days) was administered. The intrauterine inflammatory change and bacterial counts in the CZOP-treated group were compared with those in the nontreated control group. CZOP significantly (p < 0.01) decreased the bacterial counts except for B. fragilis in the regimen of 80 mg/kg b.i.d. However, the 40 mg/kg, q.i.d., regimen significantly (p < 0.05) reduced bacterial counts compared to 80 mg/kg, b.i.d. These results suggest that CZOP in a more divided dose is efficacious for the treatment of polymicrobial infections associated with E. faecalis in pyometra.

MeSH terms

  • Animals
  • Bacteroidaceae Infections / complications
  • Bacteroidaceae Infections / drug therapy
  • Bacteroidaceae Infections / microbiology
  • Bacteroides Infections / complications
  • Bacteroides Infections / drug therapy
  • Bacteroides Infections / microbiology
  • Bacteroides fragilis / drug effects
  • Bacteroides fragilis / isolation & purification
  • Cefozopran
  • Cephalosporins / administration & dosage
  • Cephalosporins / therapeutic use*
  • Colony Count, Microbial
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Endometrium / drug effects
  • Endometrium / microbiology
  • Enterococcus faecalis / drug effects*
  • Enterococcus faecalis / isolation & purification
  • Female
  • Gram-Positive Bacterial Infections / complications
  • Gram-Positive Bacterial Infections / drug therapy*
  • Gram-Positive Bacterial Infections / microbiology
  • Myometrium / drug effects
  • Myometrium / microbiology
  • Prevotella / drug effects
  • Prevotella / isolation & purification
  • Rats
  • Rats, Sprague-Dawley
  • Uterine Diseases / drug therapy*
  • Uterine Diseases / microbiology*

Substances

  • Cephalosporins